DEF: Catheter Precision Annual Meeting Proposals

Catheter Precision, Inc. has issued a proxy statement detailing proposals for its upcoming Annual Meeting of Stockholders, including director elections, reincorporation, and equity plan amendments.

Summary

• Catheter Precision, Inc. is holding its Annual Meeting of Stockholders on September 30, 2026, virtually via webcast.
• Stockholders of record as of August 18, 2026, are eligible to vote.
• Key proposals include the election of a Class II director, reincorporation from Delaware to Nevada, amendments to Series J Convertible Preferred Stock conversion price, approval of Series M Warrant exercise, an increase to the 2023 Equity Incentive Plan share reserve, a one-time stock option repricing, ratification of the independent auditor, and approval for meeting adjournment if necessary.
• The company's board of directors recommends a FOR vote on all proposals.
• The reincorporation to Nevada is expected to reduce annual state filing fees and potentially litigation risk, while offering broader director and officer protections.
• A significant proposal involves authorizing the board to reduce the conversion price of Series J Convertible Preferred Stock, which could lead to substantial dilution if lowered to $0.23 per share or below.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, as it outlines important corporate actions and proposals for stockholder approval, but does not contain financial performance updates.

Positives

• The proposed reincorporation to Nevada is expected to save approximately $200,000 annually in Delaware franchise taxes.
• Nevada law offers potentially broader protections for directors and officers compared to Delaware law.
• The company is seeking to increase its equity incentive plan share reserve by 5,000,000 shares to attract and retain talent.
• A one-time repricing of underwater stock options is proposed to restore their incentive value for employees, directors, and officers.
• The appointment of WithumSmith+Brown, PC as the independent registered public accounting firm for fiscal year 2027 is being submitted for ratification.

Negatives

• The potential reduction of the Series J Convertible Preferred Stock conversion price to as low as $0.23 per share could result in significant dilution, potentially up to approximately 217% of currently outstanding common stock.
• The issuance of up to 340,000 shares upon exercise of Series M Warrants represents approximately 12.6% dilution of outstanding common stock.
• The proposed increase to the 2023 Equity Incentive Plan adds 5,000,000 shares, which, combined with existing dilution, could significantly impact existing stockholders' proportionate equity interest.

Risks

• Significant dilution to existing stockholders is a risk if the Series J Convertible Preferred Stock conversion price is reduced substantially.
• The company's reliance on equity compensation due to limited cash resources means further dilution is possible through the equity incentive plan.
• The reincorporation to Nevada, while offering cost savings, involves a change in corporate law which could have unforeseen implications.
• The repricing of stock options, while intended to incentivize employees, could be viewed negatively by some investors due to the current low stock price.

Future Outlook

The filing does not contain specific financial future outlook or guidance. It focuses on corporate governance and operational proposals for stockholder approval.

Management Comments

• "Your vote is important."
• "We believe that Mr. Jenkins is qualified to serve as a director because of his extensive experience in the medical device industry."
• "The Board concluded that an annual election structure better serves the interests of the Company's stockholders by enhancing Board accountability, as all directors would be subject to election each year."
• "The Board believes this flexibility is in the best interests of the Company and its stockholders as it may facilitate conversion of the Series J Preferred Stock at prices that are more reflective of then-current market conditions, thereby reducing the Company's outstanding preferred equity and simplifying its capital structure."
• "The Board believes that maintaining an adequate reserve of shares available for equity compensation is critical to the Company's ability to attract, retain and incentivize the key employees, directors and consultants who will be responsible for growing the business and creating stockholder value as the Company navigates this environment."
• "Our Board of Directors believes these underwater options no longer provide the retention and performance incentives intended when they were granted, and that our ability to attract, retain, and motivate our employees, officers, and directors depends on having equity awards that provide a meaningful incentive to the holder."
• "Our Board is submitting the appointment of Withum to our stockholders because we value our stockholders' views on our independent registered public accounting firm and as a matter of good corporate governance."

Industry Context

StockSavvy.ai notes that the proposed reincorporation to Nevada is a trend seen in some companies seeking to reduce corporate costs and potentially benefit from a more business-friendly legal environment, though Delaware remains a dominant jurisdiction for corporate law. The proposals regarding equity compensation and warrant exercise are common for companies seeking to incentivize management and manage their capital structure, especially in growth phases or during periods of market volatility.

Corporate Governance

Related Party Transactions

• Issuance of 9,489.488 shares of Series J Convertible Preferred Stock to David A. Jenkins and FatBoy Capital, L.P. in exchange for the termination of certain royalty rights.
• Issuance of 340,000 Series M Common Stock Purchase Warrants (170,000 to David A. Jenkins and 170,000 to FatBoy Capital, L.P.) in connection with amendments to related-party promissory notes.

Stakeholder Impact

• Stockholders will vote on significant corporate actions that could affect their equity stake (dilution) and the company's governance structure.
• Employees, officers, and directors may benefit from the proposed stock option repricing and the increased equity incentive plan reserve.
• The reincorporation to Nevada may lead to cost savings for the company, potentially benefiting all stakeholders through redeployment of funds into operations.

Next Steps

• Stockholders to vote on the proposed resolutions at the Annual Meeting on September 30, 2026.
• If approved, the company will proceed with the reincorporation from Delaware to Nevada.
• The Board of Directors will have the authority to adjust the Series J Convertible Preferred Stock conversion price if Proposal No. 3 is approved.
• The company will proceed with the issuance of common stock upon exercise of Series M Warrants if Proposal No. 4 is approved.
• The 2023 Equity Incentive Plan will be amended to increase the share reserve if Proposal No. 5 is approved.
• Outstanding stock options will be repriced if Proposal No. 6 is approved.
• WithumSmith+Brown, PC will continue as the independent registered public accounting firm for fiscal year 2027 if Proposal No. 7 is ratified.
• The Annual Meeting may be adjourned or postponed if Proposal No. 8 is approved.

Key Dates

Recommendation

The filing outlines several proposals requiring stockholder approval, including a potentially dilutive reduction in preferred stock conversion price and an increase in the equity incentive plan. While the reincorporation to Nevada and option repricing offer some potential benefits, the significant dilution risk associated with the Series J Preferred Stock conversion warrants a cautious approach. Without current financial performance data, a 'hold' recommendation is appropriate pending further clarity on the company's operational and financial trajectory.

Keywords

Annual Meeting, Proxy Statement, Director Election, Reincorporation, Nevada, Delaware, Convertible Preferred Stock, Stock Options, Equity Incentive Plan, Warrants, Auditor Ratification